v3.26.1
Unaudited Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses        
Research and development (including $1,375,000, $4,625,000, $2,750,000 and $6,000,000 from a related party for the three months ended June 30, 2026 and 2025 and the six months ended June 30, 2026 and 2025, respectively) $ 1,400,232 $ 4,660,301 $ 2,800,507 $ 6,070,489
General and administrative (including $63,231, $65,151, $133,177 and $129,586 from related parties for the three months ended June 30, 2026 and 2025 and the six months ended June 30, 2026 and 2025, respectively) 684,015 883,727 1,467,177 1,577,837
Total operating expenses 2,084,247 5,544,028 4,267,684 7,648,326
Loss from Operations (2,084,247) (5,544,028) (4,267,684) (7,648,326)
Other expenses:        
Change in fair value of derivative liabilities (222,092) (330,719)
Total other expenses (222,092) (330,719)
Loss before income tax (2,306,339) (5,544,028) (4,598,403) (7,648,326)
Income tax provision (850) (863)
Net loss $ (2,306,339) $ (5,544,878) $ (4,598,403) $ (7,649,189)
Net loss applicable to common stock per share, basic (in Dollars per share) $ (0.05) $ (0.15) $ (0.11) $ (0.21)
Net loss applicable to common stock per share, diluted (in Dollars per share) $ (0.05) $ (0.15) $ (0.11) $ (0.21)
Weighted average common stock outstanding, basic (in Shares) 42,997,733 36,165,589 42,561,826 36,176,878
Weighted average common stock outstanding, diluted (in Shares) 42,997,733 36,165,589 42,561,826 36,176,878